Literature DB >> 22382915

Involvement of genes related to inflammation and cell cycle in idiopathic short stature.

Letizia Trovato1, Flavia Prodam, Giulia Genoni, Francesca De Rienzo, Gillian E Walker, Stefania Moia, Stefania Riccomagno, Simonetta Bellone, Gianni Bona.   

Abstract

Idiopathic Short Stature (ISS) defines a condition in which height is <-2SD compared to the mean of a reference population where systemic, endocrinological, nutritional or chromosomal disorders have not been identified and diagnosis is based on exclusion of any known causes of short stature. JAK/STAT pathway is triggered by GH binding to the GH receptor and promotes cellular growth through transcription of GH-responsive genes. In order to identify "candidate genes" differently expressed in ISS subjects with respect to control ones, we analyzed the expression of 84 genes related to JAK/STAT pathway by RT(2) Profiler PCR array approach in a total of 10 subjects. Then, we validated the observed data by Real Time PCR and ELISA assays in a major number of subjects. We found two genes that were differently expressed in ISS subjects with respect to the control group: CXCL9 and FCGR1A/CD64, both significantly up-regulated (fold change 2.17 and 1.70, respectively) and belonging to family of IFN-γ-inducible factors. Further, ISS subjects showed an increased gene expression of IFN-γ and IFI16, higher serum levels of IFN-γ but similar levels of CXCL9 when compared to healthy subjects. In addition, we showed a pubertal modulation of CXCL9 levels. These data suggest that inflammatory and regulatory factors of the cell cycle may be involved in the ISS condition, introducing a new perspective to its etiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22382915     DOI: 10.1007/s11102-012-0378-8

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  31 in total

Review 1.  Second-generation interferons for cancer: clinical targets.

Authors:  E C Borden; D Lindner; R Dreicer; M Hussein; D Peereboom
Journal:  Semin Cancer Biol       Date:  2000-04       Impact factor: 15.707

2.  Isolated GHD: investigation and implication of JAK/STAT related genes before and after rhGH treatment.

Authors:  Letizia Trovato; Stefania Riccomagno; Flavia Prodam; Giulia Genoni; Gillian E Walker; Stefania Moia; Simonetta Bellone; Gianni Bona
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 3.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

4.  Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Katerina M Antoniou; Argyris Tzouvelekis; Michael G Alexandrakis; Katerina Sfiridaki; Ioanna Tsiligianni; George Rachiotis; Nikolaos Tzanakis; Demosthenes Bouros; Joseph Milic-Emili; Nikolaos M Siafakas
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

5.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).

Authors:  E Cacciari; S Milani; A Balsamo; E Spada; G Bona; L Cavallo; F Cerutti; L Gargantini; N Greggio; G Tonini; A Cicognani
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

Review 6.  Role of chemokines in endocrine autoimmune diseases.

Authors:  Mario Rotondi; Luca Chiovato; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  Endocr Rev       Date:  2007-05-02       Impact factor: 19.871

7.  Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics.

Authors:  Wolfgang Tillinger; Ruth Jilch; Bernd Jilma; Harald Brunner; Ursula Koeller; Cornelia Lichtenberger; Thomas Waldhör; Walter Reinisch
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

8.  Defects in growth hormone receptor signaling.

Authors:  Ron G Rosenfeld; Alicia Belgorosky; Cecelia Camacho-Hubner; M O Savage; J M Wit; Vivian Hwa
Journal:  Trends Endocrinol Metab       Date:  2007-03-27       Impact factor: 12.015

9.  Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation.

Authors:  Joachim Woelfle; Dennis J Chia; Peter Rotwein
Journal:  J Biol Chem       Date:  2003-10-07       Impact factor: 5.157

Review 10.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.

Authors:  Jason C O'Connor; Robert H McCusker; Klemen Strle; Rodney W Johnson; Robert Dantzer; Keith W Kelley
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

View more
  5 in total

1.  Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.

Authors:  Kulbhushan Thakur; Divya Janjua; Gauri Shishodia; Arun Chhokar; Nikita Aggarwal; Joni Yadav; Tanya Tripathi; Apoorva Chaudhary; Anna Senrung; Alok Chandra Bharti
Journal:  Med Oncol       Date:  2022-10-12       Impact factor: 3.738

2.  LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature.

Authors:  Xijuan Liu; Jian Zhang; Jinghong Yuan; Rui Ding; Tao Liu; Jingyu Jia
Journal:  J Cell Mol Med       Date:  2022-05-24       Impact factor: 5.295

3.  Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.

Authors:  Juan F Sotos; Naomi J Tokar
Journal:  Int J Pediatr Endocrinol       Date:  2014-07-16

4.  Copy number variations in 119 Chinese children with idiopathic short stature identified by the custom genome-wide microarray.

Authors:  Guorui Hu; Yanjie Fan; Lili Wang; Ru-En Yao; Xiaodong Huang; Yiping Shen; Yongguo Yu; Xuefan Gu
Journal:  Mol Cytogenet       Date:  2016-02-16       Impact factor: 2.009

5.  A Novel Diagnostic Predictive Model for Idiopathic Short Stature in Children.

Authors:  Jinghong Yuan; Zhi Du; Zhiwen Wu; Yanqin Yang; Xigao Cheng; Xijuan Liu; Jingyu Jia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.